# Levosimendan in High Risk Patients Undergoing Cardiac Surgery

> **NCT00994825** · PHASE4 · COMPLETED · sponsor: **Università Vita-Salute San Raffaele** · enrollment: 1000 (estimated)

## Conditions studied

- Low Cardiac Output Syndrome

## Interventions

- **DRUG:** Levosimendan
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00994825
- **Lead sponsor:** Università Vita-Salute San Raffaele
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2016-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00994825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00994825, "Levosimendan in High Risk Patients Undergoing Cardiac Surgery". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00994825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*